                         SEQUENCE LISTING

<110>  Universitaet Zuerich
 
<120>  Cyclic Tetrapeptides and Metal Complexes thereof

<130>  uz452wo

<150>  EP 20211457.5
<151>  2020-12-03

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Alanin

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Alanin

<400>  1

Cys Ala Cys Ala 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  D-Cysteine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Alanine

<400>  2

Cys Ala Cys Ala 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Alanine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Alanine

<400>  3

Met Ala Met Ala 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Alanine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Alanine

<400>  4

His Ala His Ala 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Alanine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Alanine

<400>  5

Asp Ala Asp Ala 
1               


<210>  6
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Alanine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Alanine

<400>  6

Cys Ala Met Ala 
1               


<210>  7
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Alanine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Alanine

<400>  7

Cys Ala His Ala 
1               


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Alanine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Alanine

<400>  8

Cys Ala Asp Ala 
1               


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Alanine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Alanine

<400>  9

Cys Ala Phe Ala 
1               


<210>  10
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Aspartic acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Aspartic acid

<400>  10

Cys Asp Cys Asp 
1               


<210>  11
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-homoGlutamic acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-homoGlutamic acid

<400>  11

Cys Glu Cys Glu 
1               


<210>  12
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  alpha-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  head-to-tail cyclization

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  alpha-amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-amino acid

<400>  12

Xaa Xaa Xaa Xaa 
1               


<210>  13
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  beta-amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  alpha-amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  beta-amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  alpha-amino acid

<400>  13

Xaa Xaa Xaa Xaa 
1               


<210>  14
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  alpha-amino acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  alpha-amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-amino acid

<400>  14

Xaa Xaa Xaa Xaa 
1               


<210>  15
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  alpha-amino acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  head-to-tail cyclization

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  beta-Alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  alpha-amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  beta-Alanine

<400>  15

Xaa Ala Xaa Ala 
1               


<210>  16
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Aspartic acid substituted by -SH

<220>
<221>  misc_feature
<222>  (1)..(4)
<223>  head-to-tail cyclization

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  beta-Alanine

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  beta-Alanine

<400>  16

Xaa Ala Asp Ala 
1               


